Pharmacovigilance

Recognizing the need for drug safety and regulation, S2M emphasizes the crucial role of pharmacovigilance in ensuring the safety of biopharmaceutical products throughout clinical trials and post-marketing adverse drug reactions (ADR).

Pharmacovigilance
Matters

Our services encompass various aggregate reports, including Periodic Safety Update Reports (PSUR), Developmental Safety Update Reports (DSUR), and Periodic Adverse Drug Experience Reports (PADER), ensuring a comprehensive overview of drug safety profiles.

S2M provides robust support for Annual Safety Reports (ASR) and IND Annual Reports (IND), ensuring compliance with regulatory requirements and maintaining a proactive approach to drug safety.

Our team efficiently handles and reports adverse events during clinical trials, ensuring accurate documentation and adherence to regulatory guidelines.

S2M specializes in the triaging and management of post-marketing adverse drug reactions, prioritizing patient safety and regulatory compliance.

We offer comprehensive medical writing services, including narrative writing, expert statements, and investigator notifications, contributing to clear and concise documentation.

Our strength lies in our experienced team and robust IT infrastructure. We house a highly scalable global delivery model and comply with regulatory standards, including 21 CFR (Part 11) and Eudra Vigilance.

S2M conducts signal detection and evaluation, proactively identifying potential safety concerns and taking necessary actions to ensure patient welfare.

Our Unique Selling Proposition (USP) revolves around delivering high-quality, customized services within specified timelines. We integrate technology and processes, ensuring efficient data management and compliance with emerging regulatory standards.

S2M excels in seamlessly integrating and managing data in accordance with standard regulatory guidelines. Our approach ensures data accuracy, compliance, and efficiency in pharmacovigilance processes.

We facilitate electronic submissions of reports to regulators through an electronic gateway, streamlining the regulatory compliance process and ensuring timely communication.

S2M integrates our work with a robust operations team, ensuring backup support, generating status reports, and implementing new processes to meet evolving project requirements.

Pharmacovigilance

  1. Pharmacovigilance System Establishment

    Check
  2. Adverse Event Reporting

    Check
  3. Periodic Safety Reports Submission

    Check
  4. Risk Management Plan (RMP)

    Check
  5. Risk Assessment

    Check
  6. Regulatory Compliance

    Check
  7. Training and Education

    Check
  8. Patient Support Programs

    Check
  9. Communication with Regulatory Authorities

    Check
  10. Global Individual Case Safety Reports(ICSR) Submission

    Check
  11. Post-Authorization Safety Studies (PASS)

    Check
  12. Data Privacy and Security

    Check
  13. Pharmacovigilance Audits

    Check

Our service models

S2M Lifescience offers custom, scalable delivery models that get you the right resources in the right seat, when and where you need them. We are a consistent and flexible partner for your clinical programs, every step of the way.

Get in touch